Home/Filings/4/0001437749-25-001016
4//SEC Filing

LAVIOLETTE PAUL A 4

Accession 0001437749-25-001016

CIK 0001625101other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 7:45 PM ET

Size

7.8 KB

Accession

0001437749-25-001016

Insider Transaction Report

Form 4
Period: 2025-01-09
LAVIOLETTE PAUL A
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-09+1,050,0001,050,000 total
    Exercise: $18.43Exp: 2035-01-09Common Stock (1,050,000 underlying)
  • Award

    Stock Option (right to buy)

    2025-01-09+450,000450,000 total
    Exercise: $18.43Exp: 2035-01-09Common Stock (450,000 underlying)
Footnotes (2)
  • [F1]One-fourth of the shares subject to the option will vest on the three-year anniversary of the grant and the remaining shares will vest on the four-year anniversary of the grant, subject to the Reporting Person's continued service through each vesting date.
  • [F2]The shares subject to this option are subject to five tranches of performance-based vesting criteria tied to certain operating targets and the Issuer's market capitalization ranging from $3 billion to $9 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.

Issuer

PULSE BIOSCIENCES, INC.

CIK 0001625101

Entity typeother

Related Parties

1
  • filerCIK 0001191249

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 7:45 PM ET
Size
7.8 KB